• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

TIG:BB

0.5120 EUR 0.0050 0.97%

As of 07:05:57 ET on 12/24/2014.

Snapshot for TiGenix NV (TIG)

Open: 0.5110 Day's Range: 0.5100 - 0.5170 Volume: 62,429
Previous Close: 0.5170 52wk Range: 0.4800 - 1.0300 1-Yr Rtn: +2.40%

Stock Chart for TIG

No chart data available.
  • TIG:BB 0.5120
  • 1D
  • 1M
  • 1Y
0.5170
Interactive TIG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TIG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.1418
Est. EPS (EUR) (12/2014) -0.0940
Est. PEG Ratio -
Market Cap (M EUR) 82.16
Shares Outstanding (M) 160.48
30 Day Average Volume 242,428
Price/Book (mrq) 1.7039
Price/Sale (ttm) 13.7181
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TIG

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for TIG

TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.

Eduardo Bravo Fernandez De AraozCEO/Managing DirectorClaudia D AugustaCFO/Secy/Compliance Officer
Wilfried DalemansChief Technology OfficerMarie Paule RichardChief Medical Officer
More Company Profile & Key Executives for TIG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil